Viz.ai Neurovascular Impact Continues to Expand
Our latest blog focuses on the expansion of the neurovascular platforms with articles on the latest data from ISC 2022,...
Mar 15, 2022
All Resources
Explore our latest resources
Viz.ai Receives FDA 510(k) Clearance for Viz™ ANEURYSM (ANX)
Viz.ai, the world leader in artificial intelligence (AI) powered care coordination, today announced it has received U.S. Food and Drug...
Feb 24, 2022
New Data Presented at ISC 2022 Further Validates Impact of the Viz™ Platform...
Data from several new studies presented this week at the International Stroke Conference (ISC) further validates the best-in-class sensitivity and...
Feb 11, 2022
Viz.ai and TeleSpecialists Announce Strategic Partnership
Viz.ai and TeleSpecialists, LLC have entered a strategic partnership that will bring AI-powered stroke care together with leading telestroke neurologists...
Feb 09, 2022
Viz.ai Debuts Viz™ ANX, the First AI-powered Cerebral Aneurysm Detection Solution at SVIN...
Viz.ai is the leader in AI-powered care coordination and has accelerated the time-to-notification of the treatment team by 73 percent...
Nov 17, 2021
World Stroke Day 2021
Oct 29th is World Stroke Day. Read our stroke awareness blog to learn about the different types of strokes, the...
Oct 29, 2021
Neuroscience Leadership in The Age of Artificial Intelligence (Part 2)
What are the challenges that face Neuroscience Administrators in 2021, and how AI can help. Where do you really see...
Sep 28, 2021
Neuroscience Leadership in The Age of Artificial Intelligence (Part 1)
What are the challenges that face Neuroscience Administrators in 2021, and how AI can help. Some of the challenges that...
Sep 21, 2021
Acute Impact on Patient Outcomes
CMS has historically used incentives to reward hospitals for helping patients by offering a bundled payment. Advancements in technology for...
Sep 07, 2021